Chronic Myeloid Leukemia in a Patient With Multiple Sclerosis Treated With Interferon Beta-1a

Abstract

Hematological problems are commonly associated with the use of β interferon (INF) such as leukopenia and anemia, which are usually benign and reversible when the drug is stop. We described a case of of a 29 years old patient with chronic myelogenous leukemia who had received INF β-1a in the recent past for relapsing multiple sclerosis.




J Med Cases. 2016;7(10):448-450
doi: http://dx.doi.org/10.14740/jmc2622w